INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 131 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $479,000 | +506.3% | 51,629 | +113.8% | 0.04% | +1950.0% |
Q4 2019 | $79,000 | -35.2% | 24,153 | +9.8% | 0.00% | -50.0% |
Q3 2018 | $122,000 | -64.5% | 22,000 | -55.6% | 0.00% | -55.6% |
Q4 2016 | $344,000 | -18.7% | 49,600 | +9.3% | 0.01% | -35.7% |
Q3 2016 | $423,000 | -36.1% | 45,400 | -36.7% | 0.01% | -54.8% |
Q2 2016 | $662,000 | -3.1% | 71,700 | -8.7% | 0.03% | -6.1% |
Q1 2016 | $683,000 | +433.6% | 78,500 | +400.0% | 0.03% | +175.0% |
Q1 2015 | $128,000 | – | 15,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |